We are live on ! Find out more
MGNX icon

MacroGenics

147 hedge funds and large institutions have $1.23B invested in MacroGenics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

83% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 35

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

6% more funds holding

Funds holding: 139147 (+8)

3.98% less ownership

Funds ownership: 99.68%95.7% (-4%)

7% less capital invested

Capital invested by funds: $1.33B → $1.23B (-$97.7M)

52% less call options, than puts

Call options by funds: $1.76M | Put options by funds: $3.67M

Holders
147
Holders Change
+8
Holders Change %
+5.76%
% of All Funds
2.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
23
Increased
64
Reduced
35
Closed
15
Calls
$1.76M
Puts
$3.67M
Net Calls
-$1.9M
Net Calls Change
-$1.89M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$9.01M +$1.02M +44,125 +13%
Goldman Sachs
27
Goldman Sachs
New York
$8.91M +$2.45M +106,274 +37%
OM
28
Opaleye Management
Massachusetts
$8.47M -$3.6M -156,400 -30%
PA
29
Pinnacle Associates
New York
$7.82M -$1.97M -85,550 -20%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$7.43M +$2.76M +119,800 +58%
PAM
31
Panagora Asset Management
Massachusetts
$7.26M +$2.6M +112,988 +55%
RSCM
32
Rock Springs Capital Management
Maryland
$7.08M +$1.08M +46,869 +18%
GIM
33
Granahan Investment Management
Massachusetts
$6.63M +$2.44M +105,986 +58%
Arrowstreet Capital
34
Arrowstreet Capital
Massachusetts
$6.16M +$2.04M +88,670 +49%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$5.16M +$263K +11,417 +5%
BBA
36
Baker Bros. Advisors
New York
$4.59M +$4.62M +200,679 New
Principal Financial Group
37
Principal Financial Group
Iowa
$4.57M +$242K +10,521 +6%
AI
38
Atom Investors
Texas
$3.6M +$2.64M +114,723 +268%
Bank of America
39
Bank of America
North Carolina
$3.43M +$134K +5,811 +4%
Tudor Investment Corp
40
Tudor Investment Corp
Connecticut
$3.11M +$3.13M +136,085 New
Wells Fargo
41
Wells Fargo
California
$3.03M +$1.77M +76,945 +138%
Two Sigma Investments
42
Two Sigma Investments
New York
$2.94M -$809K -35,158 -21%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$2.69M -$40.2K -1,747 -1%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.66M +$239K +10,400 +10%
Massachusetts Financial Services
45
Massachusetts Financial Services
Massachusetts
$2.58M -$26.1K -1,132 -1%
JP Morgan Chase
46
JP Morgan Chase
New York
$2.53M +$2.1M +91,002 +462%
Allianz Asset Management
47
Allianz Asset Management
Germany
$2.18M +$755K +32,777 +53%
CS
48
Credit Suisse
Switzerland
$2.17M +$216K +9,384 +11%
IHAM
49
Integral Health Asset Management
New York
$2.06M
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$2M -$66.8K -2,900 -3%

MGNX Hedge Fund Activity: Q4 2020 in Review

147 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2020, worth a combined $1.23B — down 7.4% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MGNX positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 35 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $28.5M. The largest seller was Point72 Asset Management, cutting an estimated $49.2M.

  • 147 institutional investors held MacroGenics (MGNX) as of Q4 2020, up from 139 in Q3 2020.
  • Funds reported $1.23B of MacroGenics stock for Q4 2020, down 7.4% quarter-over-quarter.
  • 23 funds opened new MacroGenics positions in Q4 2020 and 15 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q4 2020 was Wasatch Advisors, an estimated $28.5M added.
  • The largest MacroGenics seller in Q4 2020 was Point72 Asset Management, an estimated $49.2M sold.

Based on aggregated 13F filings for Q4 2020.